Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 4
2004 2
2005 4
2006 5
2007 5
2008 6
2009 10
2010 7
2011 5
2012 8
2013 4
2014 6
2015 6
2016 13
2017 11
2018 5
2019 6
2020 4
2021 7
2022 5
2023 6
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Results by year

Filters applied: . Clear all
Page 1
Intravitreal Aflibercept vs Laser Therapy for Retinopathy of Prematurity: Two-Year Efficacy and Safety Outcomes in the Nonrandomized Controlled Trial FIREFLEYE next.
Stahl A, Nakanishi H, Lepore D, Wu WC, Azuma N, Jacas C, Vitti R, Athanikar A, Chu K, Iveli P, Zhao F, Leal S, Schlief S, Schmelter T, Miller T, Köfüncü E, Fielder A; FIREFLEYE next Study Group. Stahl A, et al. Among authors: azuma n. JAMA Netw Open. 2024 Apr 1;7(4):e248383. doi: 10.1001/jamanetworkopen.2024.8383. JAMA Netw Open. 2024. PMID: 38687481 Free PMC article. Clinical Trial.
Correction: Systemic exposure to aflibercept after intravitreal injection in premature neonates with retinopathy of prematurity: results from the FIREFLEYE randomized phase 3 study.
Stahl A, Azuma N, Wu WC, Lepore D, Sukgen E, Nakanishi H, Mazela J, Leal S, Pieper A, Schlief S, Eissing T, Turner KC, Zhao A, Winkler J, Höchel J, Köfüncü E, Zimmermann T; FIREFLEYE Study Group. Stahl A, et al. Among authors: azuma n. Eye (Lond). 2024 Feb 8. doi: 10.1038/s41433-024-02948-y. Online ahead of print. Eye (Lond). 2024. PMID: 38332376 No abstract available.
Systemic exposure to aflibercept after intravitreal injection in premature neonates with retinopathy of prematurity: results from the FIREFLEYE randomized phase 3 study.
Stahl A, Azuma N, Wu WC, Lepore D, Sukgen E, Nakanishi H, Mazela J, Leal S, Pieper A, Schlief S, Eissing T, Turner KC, Zhao A, Winkler J, Höchel J, Köfüncü E, Zimmermann T; FIREFLEYE Study Group. Stahl A, et al. Among authors: azuma n. Eye (Lond). 2024 Jan 10. doi: 10.1038/s41433-023-02919-9. Online ahead of print. Eye (Lond). 2024. PMID: 38200320
Clinical presentations of acquired comitant esotropia in 5-35 years old Japanese and digital device usage: a multicenter registry data analysis study.
Iimori H, Nishina S, Hieda O, Goseki T, Nishikawa N, Suzuki S, Hikoya A, Komori M, Suzuki H, Yoshida T, Hayashi S, Mori T, Kimura A, Morimoto T, Shimizu Y, Negishi T, Shimizu T, Yokoyama Y, Sugiyama Y, Azuma N, Sato M. Iimori H, et al. Among authors: azuma n. Jpn J Ophthalmol. 2023 Nov;67(6):629-636. doi: 10.1007/s10384-023-01023-5. Epub 2023 Sep 11. Jpn J Ophthalmol. 2023. PMID: 37695434
Effects of internal limiting membrane peeling on anatomical and functional outcomes in macula-off rhegmatogenous retinal detachment complicated by proliferative vitreoretinopathy: Japan-Retinal Detachment Registry.
Obata S, Sawada O, Kakinoki M, Matsumoto R, Saishin Y, Ohji M; Japan-Retinal Detachment Registry Group. Obata S, et al. Jpn J Ophthalmol. 2023 Jul;67(4):417-423. doi: 10.1007/s10384-023-01000-y. Epub 2023 Jun 8. Jpn J Ophthalmol. 2023. PMID: 37289298
118 results